KR950700740A - Compositions of Platelet Activating Factor Antagonists and Methods of Treating Interleukin-2 Induced Lung Injury Therewith - Google Patents

Compositions of Platelet Activating Factor Antagonists and Methods of Treating Interleukin-2 Induced Lung Injury Therewith

Info

Publication number
KR950700740A
KR950700740A KR1019940703602A KR19940703602A KR950700740A KR 950700740 A KR950700740 A KR 950700740A KR 1019940703602 A KR1019940703602 A KR 1019940703602A KR 19940703602 A KR19940703602 A KR 19940703602A KR 950700740 A KR950700740 A KR 950700740A
Authority
KR
South Korea
Prior art keywords
therewith
compositions
methods
lung injury
activating factor
Prior art date
Application number
KR1019940703602A
Other languages
Korean (ko)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR950700740A publication Critical patent/KR950700740A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
KR1019940703602A 1992-04-08 1994-10-07 Compositions of Platelet Activating Factor Antagonists and Methods of Treating Interleukin-2 Induced Lung Injury Therewith KR950700740A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929207645A GB9207645D0 (en) 1992-04-08 1992-04-08 Methods
PCT/US1993/003347 WO1993020822A1 (en) 1992-04-08 1993-04-08 Compositions of platelet activating factor antagonists and methods of treating interleukin-2 induced lung injury therewith

Publications (1)

Publication Number Publication Date
KR950700740A true KR950700740A (en) 1995-02-20

Family

ID=10713637

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940703602A KR950700740A (en) 1992-04-08 1994-10-07 Compositions of Platelet Activating Factor Antagonists and Methods of Treating Interleukin-2 Induced Lung Injury Therewith

Country Status (7)

Country Link
EP (1) EP0634933A1 (en)
JP (1) JPH07505885A (en)
KR (1) KR950700740A (en)
AU (1) AU4281993A (en)
CA (1) CA2133754A1 (en)
GB (1) GB9207645D0 (en)
WO (1) WO1993020822A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3502392A1 (en) * 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim NEW THIENO-TRIAZOLO-1,4-DIAZEPINO-2-CARBONIC ACID AMIDES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS
FR2601015B1 (en) * 1986-07-04 1988-08-05 Rhone Poulenc Sante NOVEL 1H, 3H-PYRROLO (1,2-C) THIAZOLE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
GB8911030D0 (en) * 1989-05-13 1989-06-28 Scras Hetrazepine derivatives

Also Published As

Publication number Publication date
EP0634933A1 (en) 1995-01-25
AU4281993A (en) 1993-11-18
GB9207645D0 (en) 1992-05-27
WO1993020822A1 (en) 1993-10-28
CA2133754A1 (en) 1993-10-28
JPH07505885A (en) 1995-06-29

Similar Documents

Publication Publication Date Title
DE69430662D1 (en) COMPOSITIONS OF HYDROCARBONS AND HYDROCARBONS
DE69406116T2 (en) CLEANING COMPOSITION AND METHOD OF USE
FI960353A (en) Agonists and antagonists of human interleukin-10
DE69225588D1 (en) AZEOTROPIC AND AZEOTROPHANIC COMPOSITIONS OF 1,1,2,2, -TETRAFLUORATHANE
DE69322395T2 (en) FIRE-RESISTANT AND HIGH-TEMPERATURE-INSULATING COMPOSITION
DE69329168T2 (en) Device for determining the properties of bones
BR9204525A (en) COMPOUND OR MIXTURE OF COMPOUNDS AND COMPOSITION
DE69124598T2 (en) SYNERGISTIC THERAPEUTIC COMPOSITIONS AND METHODS
DE69223984T2 (en) COMPOSITIONS OF DIFLUORMETHANE AND TETRAFLUORETHANE
DE69209562T2 (en) Method and device for the determination of nitrogen oxides
DE69210342T2 (en) Method and device for the rapid determination of weights
MX9205721A (en) METHOD OF USE AND COMPOSITIONS OF WIN 49596-FINASTERIDE
DE69328166D1 (en) ELIMINATION OF POLLUTANTS
DE69331757T2 (en) Cloning and expression of restriction endonucleases and modification methylases from karyophanone
DE69209293D1 (en) AZEOTROPE AND AZEOTROPARTIC COMPOSITIONS OF PENTAFLUORETHANE AND PROPANE OR ISOBUTHANE
DE69327537D1 (en) 17-BETA ARYLESTER CARBOXYLATE OF 4-AZA-5-ALPHA-ANDROSTAN-3-ONE
DE69524590T2 (en) COMPOSITION OF 5HTIDA AND 5HTID ANTAGONISTS
FI935789A0 (en) Explanation and use of explosive substances
NO940190D0 (en) Use of x-ketoglutarate
KR950700740A (en) Compositions of Platelet Activating Factor Antagonists and Methods of Treating Interleukin-2 Induced Lung Injury Therewith
FI920758A (en) COMPOSITION AND DESIGN OF SAOSOM BIOCID
DE69207051D1 (en) Substituted acetoxyazetidinone derivatives and process for the preparation of 4-acyloxyazetidinone derivatives
DE69309582T2 (en) Endless set of forms and thereby created mail piece
BR9006458A (en) FUNGICIDE COMBINATION OF SYNERGIC EFFECT AND FUNGICIDE COMPOSITION
SE8901189D0 (en) DEVICE FOR ACOUSTIC TRANSFORMATION WITH SPECIAL DESIGN OF THE SECTION AND PROPORTIONS

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid